Md. health official backs medical marijuana bill

by Brian Witte

(AP)—Maryland's health secretary is expressing support for a measure to allow medical marijuana in the state.

Secretary Joshua Sharfstein told on Friday that Gov. Martin O'Malley's administration has changed its position from last year. He says that's because the federal government has not brought charges against any state employees in other states who may have been involved with distributing medical marijuana.

Last year, the administration didn't support a similar proposal, citing concerns about potential federal prosecution of state employees.

Sharfstein says the administration is supporting the bill sponsored by Democratic Delegate Dan Morhaim of Baltimore County, with some amendments.

The bill would create a commission to oversee the program at . Morhaim says it would be "the tightest and most controlled of any state" medical marijuana program.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Arkansas court upholds medical marijuana proposal

Sep 27, 2012

(AP)—The Arkansas Supreme Court upheld a proposed ballot measure Thursday that, if successful, would make the state the first in the more conservative southern U.S. to legalize medical marijuana.

Conservative county OKs medical pot

Jul 18, 2007

Conservative Orange County, Calif., will license the use of medical marijuana and issue ID cards to patients entitled to use it.

Recommended for you

Expression of privilege in vaccine refusal

15 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments